These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7090422)

  • 1. Body residue and metabolism of adriamycin and daunorubicin in control and phenobarbital-pretreated mice.
    Bolanowska W; Gessner T
    Xenobiotica; 1982 Feb; 12(2):125-36. PubMed ID: 7090422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in adriamycin efficacy by phenobarbital.
    Reich SD; Bachur NR
    Cancer Res; 1976 Oct; 36(10):3803-6. PubMed ID: 954004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disposition and metabolism of adriamycin octanoylhydrazone (NSC 233853) in mice and rabbits.
    Egorin MJ; Clawson RE; Ross LA; Chou FT; Andrews PA; Bachur NR
    Drug Metab Dispos; 1981; 9(3):240-5. PubMed ID: 6113933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution of daunomycin and adriamycin in mice. A comparative study.
    Rosso R; Esposito M; Sala R; Santi L
    Biomedicine; 1973 Jul; 19(7):304-7. PubMed ID: 4593553
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative mammalian metabolism of adriamycin and daunorubicin.
    Loveless H; Arena E; Felsted RL; Bachur NR
    Cancer Res; 1978 Mar; 38(3):593-8. PubMed ID: 626965
    [No Abstract]   [Full Text] [Related]  

  • 6. Adriamycin and daunorubicin disposition in the rabbit.
    Bachur NR; Hildebrand RC; Jaenke RS
    J Pharmacol Exp Ther; 1974 Nov; 191(2):331-40. PubMed ID: 4417723
    [No Abstract]   [Full Text] [Related]  

  • 7. Doxorubicin and daunorubicin plasmatic, hepatic and renal disposition in the rabbit with or without enterohepatic circulation.
    Maniez-Devos DM; Baurain R; Lesne M; Trouet A
    J Pharmacol; 1986; 17(1):1-13. PubMed ID: 3713196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disposition kinetics of adriamycin, adriamycinol and their 7-deoxyaglycones in AKR mice bearing a sub-cutaneously growing ridgway osteogenic sarcoma (ROS).
    Cummings J; Merry S; Willmott N
    Eur J Cancer Clin Oncol; 1986 Apr; 22(4):451-60. PubMed ID: 3460809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacokinetics and metabolism of anthracyclines in man].
    Robert J
    Pathol Biol (Paris); 1987 Jan; 35(1):27-30. PubMed ID: 3550609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adriamycin and daunorubicin: a comparison of antitumor activities and tissue uptake in mice following immunosuppression.
    Schwartz HS; Grindey GB
    Cancer Res; 1973 Aug; 33(8):1837-44. PubMed ID: 4720795
    [No Abstract]   [Full Text] [Related]  

  • 11. Active efflux of daunorubicin and adriamycin in sensitive and resistant sublines of P388 leukemia.
    Inaba M; Kobayashi H; Sakurai Y; Johnson RK
    Cancer Res; 1979 Jun; 39(6 Pt 1):2200-3. PubMed ID: 445418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A simplified method for determination of daunorubicin, adriamycin, and their chief fluorescent metabolites in human plasma by high-pressure liquid chromatography.
    Bolanowska W; Gessner T; Preisler H
    Cancer Chemother Pharmacol; 1983; 10(3):187-91. PubMed ID: 6574828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution and metabolism of rubidazone and daunorubicin in mice.
    Baurain R; Deprez-De Campeneere D; Trouet A
    Cancer Chemother Pharmacol; 1979; 2(1):37-41. PubMed ID: 498418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Marked inter-patient variation in adriamycin biotransformation to 7-deoxyaglycones: evidence from metabolites identified in serum.
    Cummings J; Milstead R; Cunningham D; Kaye S
    Eur J Cancer Clin Oncol; 1986 Aug; 22(8):991-1001. PubMed ID: 3770056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiotoxicity and comparative pharmacokinetics of six anthracyclines in the rabbit.
    Jaenke RS; Deprez-DeCampeneere D; Trouet A
    Cancer Res; 1980 Oct; 40(10):3530-6. PubMed ID: 6934026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution and metabolism of daunomycin, adriamycin, and N-acetyldaunomycin in the Syrian golden hamster.
    Mhatre RM; Herman EH; Waravdekar VS; Lee IP
    Biochem Med; 1972 Oct; 6(5):445-53. PubMed ID: 5075698
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative cardiotoxicity and antitumour activity of doxorubicin (adriamycin) and 4'-deoxydoxorubicin and the relationship to in vivo disposition and metabolism in the target tissues.
    Cummings J; Willmott N; More I; Kerr DJ; Morrison JG; Kaye SB
    Biochem Pharmacol; 1987 May; 36(9):1521-6. PubMed ID: 3579988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic, toxicologic, and chemotherapeutic properties of detorubicin in mice: a comparative study with daunorubicin and adriamycin.
    Deprez-de Campeneere D; Baurain R; Trouet A
    Cancer Treat Rep; 1979 May; 63(5):861-7. PubMed ID: 455327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular pharmacokinetics of aclacinomycin A in cultured L1210 cells. Comparison with daunorubicin and doxorubicin.
    Zenebergh A; Baurain R; Trouet A
    Cancer Chemother Pharmacol; 1982; 8(2):243-9. PubMed ID: 6955072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of doxorubicin, (2"R)-4'-O-tetrahydropyranyl-adriamycin and aclarubicin.
    Fujita H; Ogawa K; Tone H; Iguchi H; Shomura T; Murata S
    Jpn J Antibiot; 1986 May; 39(5):1321-36. PubMed ID: 3463778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.